The Chung research group focuses on drug delivery, nanomedicine, and regenerative engineering to generate biomaterial strategies to address the limitations of clinical solutions, with a major emphasis on rare and genetic diseases. In particular, we are interested in biomimetic nanoparticles that can be designed to deliver molecular signals to report back on or influence the behavior of diseased tissue for biomedical applications. In addition, we are harnessing our expertise in combining bioactive scaffolds with novel stem cell sources for complex regeneration of hierarchically-ordered tissues and organs. Our group is highly interdisciplinary as our research is positioned at the intersection of engineering, biology, and medicine, and we work with a variety of collaborators to translate our materials towards clinical use.